Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential - Top-Institutions - MDSpire

Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential

  • By

  • Masih Kameh Khosh

  • Sascha Wellenbrock

  • Daniel Kameh Khosh

  • Tobias Hirsch

  • Abbas Agaimy

  • Dan Mon O'Dey

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Oncology
    • Pathology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Research

Original Source(s)

Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential

  • by Masih Kameh Khosh, Sascha Wellenbrock, Daniel Kameh Khosh, Tobias Hirsch, Abbas Agaimy, Dan Mon O'Dey

  • June 2, 2026

Related Content

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Effectiveness of a culturally adapted psychoeducational intervention for family caregivers of children with hematologic malignancy: a randomized controlled trial

Treatment of parotid gland oncocytoma: a case report from a radiation oncologist’s perspective